These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11808525)

  • 21. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nuchal translucency in the fetus and congenital heart defects].
    Taipale PJ; Hiilesmaa V
    Duodecim; 2001; 117(5):513-5. PubMed ID: 12116778
    [No Abstract]   [Full Text] [Related]  

  • 24. Down's syndrome screening with nuchal translucency.
    Nicolaides KH; Sebire NJ; Snijders RJ
    Lancet; 1997 Feb; 349(9049):438. PubMed ID: 9033507
    [No Abstract]   [Full Text] [Related]  

  • 25. Nuchal translucency.
    Blakemore KJ
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):388-90. PubMed ID: 9674083
    [No Abstract]   [Full Text] [Related]  

  • 26. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for heart defects in the first trimester of pregnancy: food for thought.
    Carvalho JS
    Ultrasound Obstet Gynecol; 2010 Dec; 36(6):658-60. PubMed ID: 21108303
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis.
    Makrydimas G; Sotiriadis A; Ioannidis JP
    Am J Obstet Gynecol; 2003 Nov; 189(5):1330-5. PubMed ID: 14634564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetal echocardiography at the time of the nuchal translucency scan.
    Lombardi CM; Bellotti M; Fesslova V; Cappellini A
    Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal diagnosis of structural cardiac defects.
    Allan L
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):73-6. PubMed ID: 17304544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuchal translucency and gestational age.
    Wald N; Rodeck C; Rudnicka A; Hackshaw A
    Prenat Diagn; 2004 Feb; 24(2):150-1. PubMed ID: 14974125
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
    Adekunle O; Gopee A; el-Sayed M; Thilaganathan B
    Br J Radiol; 1999 May; 72(857):457-60. PubMed ID: 10505009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-trimester nuchal translucency screening for fetal aneuploidy.
    Sherer DM; Manning FA
    Am J Perinatol; 1999; 16(3):103-20. PubMed ID: 10438192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-trimester increased nuchal translucency as a prenatal sign of Zellweger syndrome.
    Strenge S; Froster UG; Wanders RJ; Gartner J; Maier EM; Muntau AC; Faber R
    Prenat Diagn; 2004 Feb; 24(2):151-3. PubMed ID: 14974126
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fetal nuchal edema in the 11th to 14th week of pregnancy--an indication of trisomy?].
    Kuhn P
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2494-8. PubMed ID: 8571100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deriving risks of Down's syndrome from nuchal translucency measurements.
    Crossley JA; Aitken DA
    Ultrasound Obstet Gynecol; 1999 Dec; 14(6):438. PubMed ID: 10658286
    [No Abstract]   [Full Text] [Related]  

  • 39. Screening for nuchal translucency: expect or expedite?
    Herman A; Dreazen E
    Ultrasound Obstet Gynecol; 1996 Aug; 8(2):138. PubMed ID: 8883321
    [No Abstract]   [Full Text] [Related]  

  • 40. Osteogenesis imperfecta associated with increased nuchal translucency as a first ultrasound sign: report of another case.
    Viora E; Sciarrone A; Bastonero S; Errante G; Botta G; Franceschini PG; Campogrande M
    Ultrasound Obstet Gynecol; 2003 Feb; 21(2):200-2. PubMed ID: 12601849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.